Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PharmaNest’s platforms have been validated across more than 20 preclinical models and multiple clinical studies in NASH/MASH, cirrhosis, HCC, and other fibrotic diseases. Their technology enables automated quantification of over 40 traits (+350 parameters) at the single-fiber level from standard collagen-stained slides. Clinical collaborations have demonstrated that their digital biomarkers can detect treatment effects with performance comparable to or exceeding manual histopathology assessment[5][8]. The platforms are currently for research use only.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PharmaNest.